However, in our previous studies, we have demonstrated that OCT4 and CIP2A play a significant role with regard to radiosensitivity, the most crucial problem in the therapy planning of advanced HNSCC [4, 5, 8]. The gene discussed is CIP2A; the disease is head and neck squamous cell carcinoma.